AXL-IN-13
AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 of 1.6 nM and a Kd of 0.26 nM. It exhibits anticancer activity, reverses TGF-β1-induced epithelial-mesenchymal transition (EMT), and inhibits cancer cell migration and invasion.
Product Specifications
CAS Number
2376928-82-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
632.72
Molecular Formula
C34H41FN6O5
Notes
Research use only, not for human use.
Receptor
FLT | PDGFR | TGF-beta/Smad | TAM Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15372720 1 Vial
Lentiviral human CADM3 sgRNA gene knockout kit - Lentiviral human CADM3 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details MBS1278030-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock
RAP2C cDNA Clone
Sign In for Pricing
View Details MBS1278030-02 5x 0.01 mg Plasmid + 5x 0.2 mL Glycerol-Stock
RAP2C cDNA Clone
Sign In for Pricing
View Details 
MBS1214659-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O157:H7 UPF0250 protein ybeD (ybeD)
Sign In for Pricing
View Details MBS1214659-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O157:H7 UPF0250 protein ybeD (ybeD)
Sign In for Pricing
View Details MBS1214659-03 0.02 mg (Yeast)
Recombinant Escherichia coli O157:H7 UPF0250 protein ybeD (ybeD)
Sign In for Pricing
View Details